AET
Amphetamine
Alcohol
Anabolic Steroids
Anorectic Drugs
Barbiturates
Benzodiazepines
Butorphanol
Buprenorphin
Bufotenine
Chloral Hydrate
Coca Leaf
Cocaine
Codeine
Crack Cocaine
Depressants
Dextropropoxyphene
DET
DOB
DOM
DXM
Ecstasy
Ephedra
Fentanyl
Flunitrazepam
Foxy
GBL
GHB
Glutethimide
Hallucinogens
Hashish
Hash Oil
Heroin
Hemp
Hydrocodone
Hydromorphone
Ketamine
Khat
LAAM
LSD
Marijuana
Magic Mushrooms
MDA
MDMA
Meperidine
Meprobamate
Mescaline
Methadone
Methamphetamine
Methcathinone
Methaqualone
Meth Labs
Methylphenidate
Morphine
Narcotics
NEXUS
Opium
Opium Poppy
Oxycodone
OxyContin
Paraldehyde
PCP
Pentazocine
Peyote
Prescription Drugs
Ritalin
Rohypnol
Salvia Divinorum
San Pedro Cacti
STP
Thebaine
Tobacco
Tryptamines
1,4 butane diol
2C-B
5MeO-AMT
1st Responder | Drug ID Guide | Streetdrugs CD | Meth Labs DVD | Prescription Drugs | Khat | Marijuana Grow | Marijuana | Neighborhood Watch | Child Safe

Congress defined the term "dietary supplement" in the Dietary Supplement Health and Education Act (DSHEA) of 1994. A dietary supplement is a product taken by mouth that contains a "dietary ingredient" intended to supplement the diet. The "dietary ingredients" in these products may include: vitamins, minerals, herbs or other botanicals, amino acids, and substances such as enzymes, organ tissues, glandulars, and metabolites. Dietary supplements can also be extracts or concentrates, and may be found in many forms such as tablets, capsules, soft gels, gel caps, liquids, or powders. They can also be in other forms, such as a bar, but if they are, information on their label must not represent the product as a conventional food or a sole item of a meal or diet. Whatever their form may be, DSHEA places dietary supplements in a special category under the general umbrella of "foods," not drugs, and requires that every supplement be labeled a dietary supplement.
EPHEDRA (aka epitonin, ma huang, sida cordifolia, sinica) is a herbal stimulant and a main ingredient in energy-enhancing and weight loss products. Several organizations, including the American Medical Association and Health Canada have recommended banning the sale of ephedra and many other organizations, including the National Collegiate Athletics Association, the International Olympic Committee, and the National Football League, prohibit the use of products containing ephedra.
China is a major manufacturer of ephedrine and pseudoephedrine and is one of the world’s primary exporters of both chemicals. China owns and operates ephedra farms, where ephedra grass (ephedra sinica) is cultivated under strict government control. The active alkaloids, pseudoephedrine and ephedrine, are chemically extracted from the plant material and processed for pharmaceutical purposes. These chemicals are then sold domestically and internationally. China and India are the major producers of these chemicals when extracted from the ephedra plant.
In low doses, ephedrine and pseudoephedrine act as nasal decongestants. Ephedrine and pseudoephedrine are ingredients in many over-the-counter asthma medications and are also key components in illegal methamphetamine manufacturing. In high doses, the stimulant effects of these drugs can raise blood pressure and many studies have linked ephedra use to heart attacks, strokes, seizures, psychosis, insomnia and heatstroke. Those people suffering from kidney disease, liver disease, diabetes, glaucoma, heart disease or high blood pressure, thyroid disease, emphysema or chronic bronchitis, have an enlarged prostate, are pregnant or nursing, or are taking an MAOI are advised NOT to take products containing ephedrine and pseudoephedrine.
A recent study, published in the Annals of Internal Medicine and based on information collected by the American Association of Poison Control Centers concluded: * Products containing ephedra accounted for 64% of all adverse reactions to herbs in the United States, yet these products represented only 0.82% of herbal product sales. The relative risks for an adverse reaction in persons using ephedra compared with other herbs were extremely high. Even with an extreme high estimate for ephedra's share of the total herbal market (13.5%), the relative risks for adverse reactions among ephedra users were still 10- to 40-fold greater than the risk among users of other herbal products.